LEAP GRANT UPDATE: READING TOGETHER AT ARMLEY LIBRARY, PART 2
Written by Andy Parker, Better World Books Acquisitions Representative. Leeds Libraries were […]
Hello, I'm an eBook!
ATTENTION: This item is an eBook. It can be read on iOS, Android, MAC and PC's with a supported eReader. It is not a physical book. eBooks are available via download immediately after you've checked out.
May ship separately
Converts one physical book into a digital version.
eDelivery converts your used book order into a digital version readable on most devices.
Ships directly from Better World Books
Ships separately from Better World Books suppliers
The Book Cellar
Blue Fog Books
Dotcom liquidators / dc1
Super Book Deals
One Stop Text Books Store
Herb Tandree Philosophy Books
At the turn of the twenty-first century, the United States contended with a state-run biological warfare program, bioterrorism, and a pandemic. Together, these threats spurred large-scale government demand for new vaccines, but few new have materialized. A new anthrax vaccine has been a priority since the first Gulf War, but twenty years and a billion dollars later, the United States still does not have one. This outcome is as puzzling as it is troubling.
Historically, the United States has excelled at responding to national health emergencies. World War II era programs developed ten new or improved vaccines, often in time to meet the objectives of particular military missions. Probing the history of vaccine development for factors that foster timely innovation, Kendall Hoyt discovered that vaccine innovation has been falling, not rising, since World War II. This finding is at odds with prevailing theories of market-based innovation and suggests that a collection of nonmarket factors drove mid-century innovation. Ironically, many late-twentieth-century developments that have been celebrated as a boon for innovation--the birth of a biotechnology industry and the rise of specialization and outsourcing--undercut the collaborative networks and research practices that drove successful vaccine projects in the past.
Hoyt's timely investigation teaches important lessons for our efforts to rebuild twenty-first-century biodefense capabilities, especially when the financial payback for a particular vaccine is low, but the social returns are high.
Our best deal on used books 3 for $10 and just $3 each additional book. Shop and Save
A great last-minute present. Exactly what they want to read. Order Gift Certificates »
We match every book you purchase with a book donation. Learn more »
Sign up now to get news, sales and special promotions!
© Better World Books (BetterWorldBooks.com)